Palvella Therapeutics, Inc.

PVLA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$63,567$70,433$75,626$83,602
Short-Term Investments$0$0$0$0
Receivables$2,216$1,978$1,978$2,336
Inventory$0$0$0$0
Other Curr. Assets$1,154$1,336$1,835$2,296
Total Curr. Assets$66,937$73,747$79,439$88,234
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$0$0$0$0
Other Assets$0$0$0$0
Total Assets$66,937$73,747$79,439$88,234
Liabilities
Payables$3,481$4,557$4,441$4,586
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$6,831$5,059$4,542$7,452
Total Curr. Liab.$10,312$9,616$8,983$12,038
LT Debt$0$14,511$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$17,943$1,840$14,879$13,589
Total NC Liab.$17,943$16,351$14,879$13,589
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$28,255$25,967$23,862$25,627
Equity
Pref Stock$0$0$0$0
Common Stock$11$11$11$11
Retained Earnings-$122,736-$111,391-$101,920-$93,735
AOCI$104-$111-$3$3
Other Equity$161,303$159,271$157,489$156,328
Total Equity$38,682$47,780$55,577$62,607
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$66,937$73,747$79,439$88,234
Net Debt-$63,567-$55,922-$75,626-$83,602